Post-Mortem Tax Planning for a Pharmacy Corporation: The Pipeline and 164(6) Strategies

Death, while inevitable, should not result in unnecessary double taxation. For a pharmacist who spent decades building a professional corporation, dying as the shareholder can create a perfect storm — a deemed disposition of shares, corporate tax on retained earnings, and loss of the exemption if planning is neglected. Fortunately, Canadian tax law provides several techniques, collectively known as post-mortem tax planning, that can eliminate or mitigate this double tax. This article, derived from Dale Barrett's Tax-Wise Estate Planning for Pharmacists, explains the two most common tools and the executor's role in carrying them out.

Why does a pharmacist's estate risk being taxed twice?

When a pharmacist dies owning shares of a professional corporation, tax can arise twice unless planned otherwise. At Stage 1, the deemed disposition at death, Income Tax Act section 70(5) treats the deceased as having sold all capital property — including corporate shares — at fair-market value immediately before death, creating a capital gain on the shares (the exemption may shelter some or all of it if the corporation is a QSBC).

At Stage 2, corporate-level tax, the same corporate earnings that increased the share value remain inside the corporation and are taxed again when later distributed to the estate or heirs as dividends. Without planning, the estate effectively pays tax twice on the same value.

How big can the double-tax problem be?

The book illustrates the scale with a corporation whose shares have a fair-market value of $2,000,000 and an adjusted cost base of $100,000, holding $1,800,000 in retained earnings. The estate realizes a capital gain of about $1.9M, and when the retained earnings are later distributed there is a further dividend tax of roughly $800,000 — a total burden in the range of $1.1M–$1.3M that is largely avoidable with planning.

What is the pipeline strategy? (step by step)

The pipeline eliminates double taxation by allowing the estate to extract retained earnings as a capital repayment instead of a dividend. It is best when the goal is to continue operations or sell the pharmacy rather than wind it up. The steps are:

  • Step 1 — Death and estate creation: the estate inherits the shares at fair-market value, and the deceased reports a capital gain on the final return
  • Step 2 — Incorporate a new company ('Newco')
  • Step 3 — Transfer shares to Newco: the estate transfers the deceased's professional corporation ('Opco') to Newco under a section 85(1) rollover, receiving a promissory note equal to the fair-market value of the shares
  • Step 4 — Wind up or amalgamate: Newco and Opco amalgamate, or Opco is wound up into Newco, so the retained earnings become available as safe paid-up capital or a tax-free return of capital
  • Step 5 — Gradual repayment: over time Newco repays the estate's promissory note using Opco's retained earnings, treated as a capital repayment rather than a taxable dividend
  • Step 6 — Timing: CRA generally requires a reasonable delay (often around 12 months) between amalgamation and repayment to confirm the pipeline's bona fide purpose and avoid recharacterization as a dividend

When is the 164(6) loss carry-back a better fit?

If liquidation is preferable to continuation, subsection 164(6) offers another route. The estate elects to sell the inherited shares back to Opco for fair-market value, realizing a capital loss; that loss is applied against the capital gain reported on the deceased's final return, refunding part of the tax; and Opco redeems the shares and pays a deemed dividend, taxed at the corporate or estate level.

It is simpler and faster than the pipeline and generates an immediate tax refund for the estate, making it suitable when the corporation will be wound up shortly after death. The trade-offs: it may cause high dividend tax if retained earnings are large, and the CRA filing deadlines are strict — generally within one year of death. The book's rule of thumb: use 164(6) when the goal is liquidation; use the pipeline when continuing operations or selling the pharmacy is preferable.

How does life insurance fit post-mortem planning?

Corporate-owned life insurance complements post-mortem planning by providing liquidity and CDA credits. On death, the Holdco or Opco receives the insurance proceeds tax-free; the proceeds (minus the policy's adjusted cost basis) create a CDA credit; the estate receives tax-free capital dividends from the corporation to pay personal tax or fund a share redemption; and a pipeline or 164(6) transaction then eliminates any residual double taxation. The combination ensures taxes are funded without selling assets or jeopardizing pharmacy operations.

What must the executor's authority and the will include?

Post-mortem strategies only work if the executor has clear authority. The will should expressly empower the executor to implement pipeline or loss-carry-back transactions, to amalgamate, wind up or continue the corporation, to sign and file all tax elections, and to retain accountants and lawyers to execute the plan. The book offers a sample clause along these lines: 'My Trustee may reorganize, amalgamate, or liquidate any corporation in which I hold an interest and may implement any transactions, elections, or reorganizations that my accountant or tax advisor recommends to minimize taxes payable by my estate.' Where secondary (dual) wills cover corporate assets, ensure both grant equivalent post-mortem powers.

Regulatory deadlines run in parallel. A professional corporation cannot operate indefinitely under a deceased shareholder, so each College imposes transfer deadlines — in Ontario, for example, notify the College within 30 days of death, transfer shares to a licensed pharmacist within the prescribed period, and designate a new pharmacist-director or manager. If no pharmacist heir exists, plan the share sale or wind-up in advance within the will or shareholders' agreement.

This is general information, not legal or tax advice. Pharmacy ownership rules vary by province and tax thresholds change — confirm the current rules with a qualified tax lawyer and accountant before acting.

Frequently asked questions

What is double taxation on death for a corporation?
It is being taxed twice on the same value: once as a capital gain when the deceased is deemed to have sold the shares at death, and again as a dividend when the corporation's retained earnings are later distributed to the estate or heirs. Post-mortem planning is designed to eliminate one of those layers.
What is a pipeline transaction?
A reorganization in which the estate transfers the deceased's corporation to a new company and repays itself with the retained earnings as a capital repayment rather than a taxable dividend, so only the capital gain at death is taxed. CRA expects a reasonable delay (often about a year) before repayment.
When should an executor use 164(6) instead?
When the corporation will be wound up shortly after death. The 164(6) loss carry-back is simpler and produces an immediate tax refund, but it can trigger high dividend tax if retained earnings are large and must be filed within one year of death.
How does insurance help the executor?
Corporate-owned life insurance delivers tax-free cash and a capital dividend account credit on death, giving the estate liquidity to pay taxes and redeem shares without a fire sale. A pipeline or 164(6) step then removes any remaining double tax.
What clauses should be in a pharmacist's will for this?
Express authority for the executor to amalgamate, wind up or continue the corporation, to implement pipeline or loss-carry-back transactions, and to sign all tax elections — and, where dual wills exist, equivalent powers in both. Without these clauses the executor may be unable to act in time.
How quickly must the College be notified after an owner's death?
Deadlines are short and vary by province. Ontario generally requires notification within 30 days, transfer of shares to a licensed pharmacist within a prescribed period, and designation of a new pharmacist-director or manager.